Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Emtricitabine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 17 USDMF, 2 JDMF, 16 EU WC, 5 KDMF, 19 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

177 FDF Dossiers, 56 FDA Orange Book, 32 Europe, 24 Canada, 52 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 10 DKSH, 6 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 32 Controlled & Modified Release, 25 Thickeners and Stabilizers, 22 Granulation, 21 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 16 Topical, 15 Lubricants & Glidants, 12 Film Formers & Plasticizers, 11 Taste Masking, 9 Co-Processed Excipients, 9 Empty Capsules, 9 Parenteral, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 192 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 29 Regulatory FDF Prices, 55 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 8 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Arene Lifesciences	India	ARENE LIFE SCIENCES PRIVATE LTD	34105	EMTRICITABINE	2019-10-17	Active	II	N/A
28/03/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LTD	20708	EMTRICITABINE (NON-STERILE) DRUG SUBSTANCE	2007-07-18	Active	II	Complete	2017-12-01	2017-10-11

Emtricitabine

Emtricitabine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

17 USDMF

2 JDMF

16 EU WC

5 KDMF

19 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

177 FDF Dossiers

56 FDA Orange Book

32 Europe

24 Canada

52 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG

TABLET;ORAL - 150MG;150MG;200MG;300MG

TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE

TABLET;ORAL - 120MG;EQ 15MG BASE

TABLET;ORAL - 200MG;EQ 25MG BASE

TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE

TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE

TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

CAPSULE;ORAL - 200MG

TABLET;ORAL - 100MG;150MG

TABLET;ORAL - 133MG;200MG

TABLET;ORAL - 167MG;250MG

TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

4 SPI Pharma

10 DKSH

6 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

4 ACG Worldwide

5 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

26 BASF

10 Corel Pharma Chem

5 DFE Pharma

2 Finar

8 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

31 Kerry

3 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

2 Nomisma Healthcare

3 Novo Excipients

2 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

16 Roquette

9 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders